Investor Relations & External Communications
Discover our resources
Resource types
Topics
-
Download Info Sheet Investor Relations & External Communications
-
Download Key Insights Key Insights - Beyond Geography: A Former Regulator’s Perspective on Multiregional Oncology Trials
Key Insights - Beyond Geography: A Former Regulator’s Perspective on Multiregional Oncology Trials
-
Download Article AAPS Assessment of Immune Responses Against AAV Encoded Transgene Products (2025)
AAPS Assessment of Immune Responses Against AAV Encoded Transgene Products (2025)
-
Download Infographic Comprehensive Multi-Omics Approach to Support Biomarker Programs
Comprehensive Multi-Omics Approach to Support Biomarker Programs
-
Download Poster Validated 32-color High-Dimensional Flow Panel for Comprehensive Immune Profiling – Pharmacodynamic Biomarker Discovery for Solid Tumor I-O Clinical Trials
Validated 32-color High-Dimensional Flow Panel for Comprehensive Immune Profiling – Pharmacodynamic Biomarker Discovery for Solid Tumor I-O Clinical Trials
-
Download Whitepaper Optimizing Development of Viral Vector Gene Therapies and Companion Diagnostics in the US
Optimizing Development of Viral Vector Gene Therapies and Companion Diagnostics in the US
-
Download Article Tumor-localized CD40 agonism with MP0317, a FAP x CD40 DARPin, reprograms the tumor microenvironment in patients with advanced solid tumors: an open-label, nonrandomized, dose-escalation phase 1 study
Tumor-localized CD40 agonism with MP0317, a FAP x CD40 DARPin, reprograms the tumor microenvironment in patients with advanced solid tumors: an open-label, nonrandomized, dose-escalation phase 1 study
-
Download Poster Flow Cytometry-Based Monitoring of CAR-T cell Persistence and Immune Phenotypes Pre and Post-Infusion-Gating Challenges in Phase 1-2 Hematologic Malignancy Trials
Flow Cytometry-Based Monitoring of CAR-T cell Persistence and Immune Phenotypes Pre and Post-Infusion-Gating Challenges in Phase 1-2 Hematologic Malignancy Trials
